Multiple Manufacturers

ANGIOMAX

Manufacturer:

Multiple Manufacturers

Angiomax HCPCS:

J0583

HCPCS Code Descriptor:

Injection, bivalirudin, 1 mg

Category:

J Code

Angiomax NDCs:

00409-8300-10, 55150-0210-10, 67457-0256-10, 70860-0402-10, 71288-0427-11, 70860-0403-51, 63323-0562-10, 00409-8300-15, 00781-3447-95, 55111-0652-37, 60505-6101-04, 00338-9572-24, 70436-0025-82, 42023-0622-10, 16729-0275-67, 00781-9158-95, 00781-3158-95, 63323-0562-15, 72572-0035-10, 83634-0400-10

Primary Type:

Anti-coagulant

Generic/Specialty Status:

Multi-Source

Package Type:

Multiple

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00409-8300-10, 55150-0210-10, 67457-0256-10, 70860-0402-10, 71288-0427-11, 70860-0403-51, 63323-0562-10, 00781-3447-95, 55111-0652-37, 60505-6101-04, 00338-9572-24, 70436-0025-82, 42023-0622-10, 16729-0275-67, 00781-9158-95, 00781-3158-95, 63323-0562-15, 72572-0035-10, 83634-0400-10

About Angiomax:

ANGIOMAX is a medication manufactured by multiple manufacturers and aligned to the J Code: J0583. ANGIOMAX is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0583 Added Date:

January 1, 2004

J0583 Effective Date:

January 1, 2018

J0583 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Angiomax billing and coding information.
Our team did not identify a source for Angiomax patient assistance information. Please reach out to our team if you feel that this is a mistake.
ANGIOMAX prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for ANGIOMAX. Please check back in a few weeks.